PROTEOSTASIS THERAPEUTICS

Proteostasis Therapeutics is discovering and developing novel small molecule therapeutics designed to control the body's protein homeostasis, or Proteostasis Network. The Proteostasis Network maintains the body's natural balance of proteins to protect us from numerous diseases. These novel therapies, or Proteostasis Regulators, are designed to treat multiple genetic and degenerative disorders associated with deficiencies of the Proteostasis Network, such as emphysema, type II diabetes, Alzheimer's Disease and Huntington's Disease.
PROTEOSTASIS THERAPEUTICS
Industry:
Biotechnology Medical Therapeutics
Founded:
2007-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.proteostasis.com
Total Employee:
51+
Status:
Active
Contact:
6172257801
Total Funding:
105.01 M USD
Technology used in webpage:
SPF Domain Not Resolving Microsoft Exchange Online Office 365 Mail IPv6 ReCAPTCHA V2 Microsoft GlobalSign GlobalSign Domain Verification Akamai Hosted
Similar Organizations
AptamiR Therapeutics
AptamiR Therapeutics is a biotechnology company that focuses on developing a revolutionary treatment for human obesity.
Boston Immune Technologies & Therapeutics
This company is a Boston-based biopharmaceutical company developing immune-based approaches.
Chroma Medicine
Chroma Medicine is a new genomic medicine company working on epigenetic editing.
Intensity Therapeutics
Intensity Therapeutics is a biopharmaceutical company that provides chemotherapy treatment for cancer patients.
Juventas Therapeutics
Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.
Ligature Therapeutics
Ligature Therapeutics is a biotech company that develops small molecules for targeted protein degradation to treat intractable diseases.
Marker Therapeutics
Marker Therapeutics is a clinical-stage developer of a transformative, non-genetically engineered, multi-antigen T cell therapy platform.
MSI Methylation Sciences
MSI Methylation Sciences is a biotechnology company that develops and markets S-Adenosyl Methionine.
Orpro Therapeutics
OrPro Therapeutics develops recombinant thioredoxin for the treatment of cystic fibrosis.
Rhovac ApS
RhoVac is an immuno-oncology company developing a novel therapeutic cancer vaccine that targets metastatic cancer cells.
Ceptur Therapeutics
Revolutionizing gene silencing by developing targeted oligonucleotide therapeutics based on U1 Adaptor technology
SiteOne Therapeutics
SiteOne Therapeutics is a San Francisco-based company that develops novel therapeutics and diagnostics.
Tetra Therapeutics
Tetra Therapeutics is a clinical stage biotechnology company developing a portfolio of therapeutic products.
Thesan Pharmaceuticals
Thesan Pharmaceuticals is a preclinical biopharmaceutical company developing novel therapeutics for skin disorders.
Transition Therapeutics
Transition Therapeutics is a biopharmaceutical company developing novel therapeutics for disease indications with large markets.
Current Advisors List
Board_member
Board_member
Board_member
Current Employees Featured
Janet Smart Senior Vice President, Legal Affairs @ Proteostasis Therapeutics
Senior Vice President, Legal Affairs
2020-03-01
Dean Richard Morimoto Founder @ Proteostasis Therapeutics
Founder
Marija Zecevic Chief Business Officer @ Proteostasis Therapeutics
Chief Business Officer
2017-04-01
Randall King Cofounder @ Proteostasis Therapeutics
Cofounder
2011-01-01
Geoffrey Gilmartin Chief Medical Officer @ Proteostasis Therapeutics
Chief Medical Officer
Ben Munoz Chief Scientific Officer @ Proteostasis Therapeutics
Chief Scientific Officer
2017-01-01
Helen Boudreau CFO @ Proteostasis Therapeutics
CFO
2017-07-01
Jeffery W. Kelly Co-Founder @ Proteostasis Therapeutics
Co-Founder
Sheila Wilson Vice President, Clinical Operations @ Proteostasis Therapeutics
Vice President, Clinical Operations
2016-01-01
Po-Shun Lee Chief Medical Officer and EVP @ Proteostasis Therapeutics
Chief Medical Officer and EVP
2014-01-01
Founder
Stock Details
Investors List
Cormorant Asset Management
Cormorant Asset Management investment in Series B - Proteostasis Therapeutics
Sanofi Ventures
Sanofi Ventures investment in Series B - Proteostasis Therapeutics
Novartis Venture Fund
Novartis Venture Fund investment in Series B - Proteostasis Therapeutics
HealthCare Ventures
HealthCare Ventures investment in Series B - Proteostasis Therapeutics
F-Prime Capital
F-Prime Capital investment in Series B - Proteostasis Therapeutics
Rock Springs Capital
Rock Springs Capital investment in Series B - Proteostasis Therapeutics
New Enterprise Associates
New Enterprise Associates investment in Series B - Proteostasis Therapeutics
Elan Corporation
Elan Corporation investment in Venture Round - Proteostasis Therapeutics
HealthCare Ventures
HealthCare Ventures investment in Series A - Proteostasis Therapeutics
Novartis Venture Fund
Novartis Venture Fund investment in Series A - Proteostasis Therapeutics
Official Site Inspections
http://www.proteostasis.com
- Host name: apache2-dap.pdx1-shared-a1-36.dreamhost.com
- IP address: 69.163.180.60
- Location: Brea United States
- Latitude: 33.9339
- Longitude: -117.8854
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 92821

More informations about "Proteostasis Therapeutics"
Proteostasis Consortium
The Proteostasis Consortium is a group of investigators who have worked together on proteostasis in biology, health, and diseases. Together, we have contributed fundamental insights on biochemical mechanisms of protein …See details»
The proteostasis network and its decline in ageing - Nature
Feb 7, 2019 This proteostasis network declines with age, which can be linked to human degenerative diseases. ... Understanding the organization of this network and its regulation in …See details»
Proteostasis - Wikipedia
Proteostasis is the dynamic regulation of a balanced, functional proteome. The proteostasis network includes competing and integrated biological pathways within cells that control the biogenesis, folding, trafficking, and degradation of proteins present within and outside the cell. Loss of proteostasis is central to understanding the cause of diseases associated with excessive protein misfolding and degradation leading to loss-of-function phenotypes, as well as aggregation-associ…See details»
The Biology of Proteostasis in Aging and Disease - PMC
Loss of protein homeostasis (proteostasis) is a common feature of aging and disease that is characterized by the appearance of nonnative protein aggregates in various tissues. ... Here, …See details»
Proteostasis Therapeutics - Crunchbase Company Profile & Funding
The Proteostasis Network maintains the body's natural balance of proteins to protect us from numerous diseases. These novel therapies, or Proteostasis Regulators, are designed to treat …See details»
PROTEOSTASIS: A European Network to Break Barriers and …
May 1, 2019 Whether from the academic or the private sector, the PROTEOSTASIS network helped scientists to develop fundamental or translational research thanks to the multiple …See details»
PROTEOSTASIS: A European Network to Break Barriers …
Feb 15, 2019 Protein homeostasis (proteostasis) is at the core of cellular functions. The European network PROTEOSTASIS was created to steer research and foster collaborations in the interconnected fields of posttranslational …See details»
Functional Modules of the Proteostasis Network - PMC
Chaperones serve as the main conductors of proteostasis by directly influencing the “foldedness” of the proteome. They typically do so by binding to hydrophobic polypeptide segments that are …See details»
COST ACTION BM1307 PROTEOSTASIS
The COST Action PROTEOSTASIS BM1307 is an European network with members from almost all countries in Europe. Its main objective is to facilitate research and collaborations in the …See details»
PROTEOSTASIS: A European Network to Break Barriers and …
Vate sector, the PROTEOSTASIS net-work helped scientists to develop fundamental or translational research thanks to the multiple instruments that it offered to the community, …See details»
Proteostasis: From translation to degradation - EMBO
Sep 1, 2023 This third edition of the EMBO workshop on Proteostasis focuses on promoting an integrated understanding of the proteostasis network.The proteostasis network is the collection of biological mechanisms that assure …See details»
Shaping proteostasis at the cellular, tissue, and organismal level
The specific proteomes that support the organization and function of different cell types in multicellular organisms represent an additional layer of complexity to proteostasis regulation. …See details»
Diversity in the origins of proteostasis networks - Nature
Mar 6, 2013 This proteostasis network has co-evolved with the proteome and is thought to play a part in driving evolution. ... Describes the fundamental role of HSP90 in directing the …See details»
Organization of the Proteostasis Network of Membraneless …
Nov 15, 2024 Membraneless organelles (MLOs) are dynamic macromolecular condensates that act as crucibles to modulate biological process within the cell. Since MLOs form in the …See details»
Organization of the Proteostasis Network of Membraneless …
Nov 12, 2024 Organization of the Proteostasis Network of Membraneless Organelles Christine M. Lim 1, Yuqi Bian , Alicia González Díaz , Frank Pun2, Alex Zhavoronkov2, Richard I. …See details»
Activators of the 26S proteasome when protein degradation …
Jan 8, 2025 Among other modifications, ADP-ribosylation is known to stimulate the activity of the 20S proteasome upon H 2 O 2 treatment or neuroinflammatory stimulation, such as TNF-α …See details»
Pathways of cellular proteostasis in aging and disease - PMC
Klaips et al. outline the pathways and molecular mechanisms of cellular protein homeostasis, or proteostasis, and discuss how a decline in proteostasis during aging contributes to disease. ...See details»
Loss of proteostasis and age-related diseases | Lifespan.io
Aug 11, 2017 Proteostasis is the process that cells perform in order to have all their proteins functioning properly. Aging causes this process to fail, leading to diseases. ... Steve is the …See details»
Proteostasis restoration: a new metric for tau immunotherapy …
Jan 7, 2025 Proteostasis refers to the balance between protein synthesis, folding, modification and degradation. As all of these processes are disrupted in Alzheimer’s disease, 7 restoring …See details»
Protein Folding and Mechanisms of Proteostasis - PMC
This breakdown of proteostasis [89,91] can lead to a situation that is known as protein metastasis, ... The organization and evolutionary dynamics of the proteome provide a line of defense in …See details»